These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35080320)

  • 21. COVID-19 Vaccines in Children with Cow's Milk and Food Allergies.
    Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Mori F; Paglialunga C; Saretta F; Caffarelli C
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reasons for allergology consultations prior to COVID-19 vaccination and their outcomes : Two-year experience of an allergy center in North Rhine-Westphalia].
    Leonidou Floruß E; Demidova A; Hofmann SC; Balakirski G
    Dermatologie (Heidelb); 2023 Jul; 74(7):511-519. PubMed ID: 37140637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.
    Macy E; Pandya S; Sheikh J; Burnette A; Shi JM; Chung J; Gin N; Crawford W; Zhang J
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):827-836. PubMed ID: 34971845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity.
    Zarnegar-Lumley S; Stone CA; Smith CM; Hall LL; Luck KE; Koo G; Plager JH; Phillips EJ; Friedman DL
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29686. PubMed ID: 35353440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns.
    Kaddis T; Joshi S; Anstey KM
    Allergy Asthma Proc; 2022 Sep; 43(5):431-434. PubMed ID: 36065101
    [No Abstract]   [Full Text] [Related]  

  • 26. COVID-19 mRNA vaccine allergy.
    Risma KA
    Curr Opin Pediatr; 2021 Dec; 33(6):610-617. PubMed ID: 34670264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives.
    Sampath V; Rabinowitz G; Shah M; Jain S; Diamant Z; Jesenak M; Rabin R; Vieths S; Agache I; Akdis M; Barber D; Breiteneder H; Chinthrajah S; Chivato T; Collins W; Eiwegger T; Fast K; Fokkens W; O'Hehir RE; Ollert M; O'Mahony L; Palomares O; Pfaar O; Riggioni C; Shamji MH; Sokolowska M; Jose Torres M; Traidl-Hoffmann C; van Zelm M; Wang Y; Zhang L; Akdis CA; Nadeau KC
    Allergy; 2021 Jun; 76(6):1640-1660. PubMed ID: 33811364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions.
    Pitlick MM; Sitek AN; D'Netto ME; Dages KN; Chiarella SE; Gonzalez-Estrada A; Joshi AY; Park MA
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):153-160. PubMed ID: 34798275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CoronaVac/Sinovac COVID-19 Vaccine-Related Hypersensitivity Reactions and Second-Dose Vaccine Administration: Tertiary Allergy Center Experience.
    Gumusburun R; Dalgıc CT; Mete Gokmen EN; Sin AZ
    Int Arch Allergy Immunol; 2022; 183(7):778-784. PubMed ID: 35462361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Allergic reactions to COVID-19 vaccines: evidence and practice-oriented approach].
    Klimek L; Eckrich J; Hagemann J; Casper I; Huppertz J
    Internist (Berl); 2021 Mar; 62(3):326-332. PubMed ID: 33580823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions].
    Fallet B; Miauton A; Comte D; Ribi C; Muller YD
    Rev Med Suisse; 2021 Apr; 17(733):690-696. PubMed ID: 33830701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinating Children against Covid-19 - The Lessons of Measles.
    Klass P; Ratner AJ
    N Engl J Med; 2021 Feb; 384(7):589-591. PubMed ID: 33471977
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System.
    Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC
    JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
    Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
    [No Abstract]   [Full Text] [Related]  

  • 37. Allergic reactions to COVID-19 vaccinations-unveiling the secret(s).
    Pfaar O; Mahler V
    Allergy; 2021 Jun; 76(6):1621-1623. PubMed ID: 33432606
    [No Abstract]   [Full Text] [Related]  

  • 38. Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions.
    Messina MR; Crisciotti C; Pellegrini L; Nappi E; Racca F; Costanzo G; Del Moro L; Ferri S; Puggioni F; Canonica GW; Heffler E; Paoletti G
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate.
    Hartono SP; Sharma HP; Bundy V; Thompkins JD; Kochis SR; Brooks JP
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2172-2175.e1. PubMed ID: 35842413
    [No Abstract]   [Full Text] [Related]  

  • 40. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
    Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA
    Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.